|
SGMS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.280400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.426400E-02 |
| Normal-vs-Stage2 |
1.265540E-02 |
| Normal-vs-Stage3 |
2.509700E-02 |
| Normal-vs-Stage4 |
2.180200E-01 |
| Stage1-vs-Stage2 |
3.904800E-01 |
| Stage1-vs-Stage3 |
5.417000E-01 |
| Stage1-vs-Stage4 |
9.958600E-01 |
| Stage2-vs-Stage3 |
9.727600E-01 |
| Stage2-vs-Stage4 |
6.866000E-01 |
| Stage3-vs-Stage4 |
7.005200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.060500E-03 |
| Normal-vs-AfricanAmerican |
2.991900E-02 |
| Normal-vs-Asian |
9.779900E-02 |
| Caucasian-vs-AfricanAmerican |
5.077600E-01 |
| Caucasian-vs-Asian |
5.525400E-01 |
| AfricanAmerican-vs-Asian |
3.277400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.075350E-03 |
| Normal-vs-Female |
1.786950E-01 |
| Male-vs-Female |
5.947700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.238100E-03 |
| Normal-vs-Extreme_Weight |
8.764400E-03 |
| Normal-vs-Obese |
8.303600E-02 |
| Normal-vs-Extreme_Obese |
5.263500E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.503800E-01 |
| Normal_Weight-vs-Obese |
1.500980E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.832400E-01 |
| Extreme_Weight-vs-Obese |
2.701000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.471400E-01 |
| Obese-vs-Extreme_Obese |
8.300100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.871800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.119450E-01 |
| Normal-vs-Age(61-80Yrs) |
2.802100E-03 |
| Normal-vs-Age(81-100Yrs) |
6.060000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.007000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.497700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.281000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.457900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.066000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.255800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.176500E-02 |
| Normal-VS-Type2 PRCC |
1.695560E-03 |
| Normal-VS-KIRP CIMP |
8.275000E-01 |
| Normal-VS-Unclassified PRCC |
1.137370E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.372240E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.012000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.319800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.398240E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.198030E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.892200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.795850E-03 |
| Normal-vs-N1 |
5.103600E-02 |
| Normal-vs-N2 |
5.680800E-01 |
| N0-vs-N1 |
3.789000E-01 |
| N0-vs-N2 |
3.317000E-01 |
| N1-vs-N2 |
6.897400E-01 |
|
|
